WuXi Biologics (Cayman) Inc.
OTC: WXIBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zhisheng Chen
- Employees
- 12,575
- Headquarters
- Wuxi, China
- IPO year
- 2018
- Market cap
- $16.6B
- Website
- https://www.wuxibiologics.com
Loading WXIBF…
Loading profile data…Frequently asked questions about WXIBF
What does WuXi Biologics (Cayman) Inc. (WXIBF) do?
WuXi Biologics (Cayman) Inc. provides extensive global services, spanning the entire biopharmaceutical process from drug discovery to advanced development and manufacturing, catering to clients in China, North America, Europe, and other international markets. The company also offers expert consultation in biopharmaceutical technology, facilitate...
Where does WXIBF trade?
WuXi Biologics (Cayman) Inc. (WXIBF) trades on the Other OTC.
What sector is WXIBF in?
WuXi Biologics (Cayman) Inc. (WXIBF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of WuXi Biologics (Cayman) Inc.?
Zhisheng Chen is the chief executive officer of WuXi Biologics (Cayman) Inc. (WXIBF).
Where is WuXi Biologics (Cayman) Inc. headquartered?
WuXi Biologics (Cayman) Inc. is headquartered in China.
Does WXIBF pay a dividend?
WuXi Biologics (Cayman) Inc. (WXIBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WXIBF go public?
WuXi Biologics (Cayman) Inc. (WXIBF) completed its initial public offering in 2018.